RNU6-489P

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RNU6-489P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNU6-489P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RNU6-489P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-489P expression acts as an unfavorable survival marker.

KIRP and THCA are the cancer types where RNU6-489P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRPOSTertileAll0.5800.903<.00181view →
THCADFSTertileAll0.0490.828<.00154view →
Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RNU6-489P–KIRP (OS)

Kaplan–Meier survival curve for RNU6-489P RNA-high vs -low samples in KIRP.

Open the KIRP breakdown →

Exploration